Cargando…
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
BACKGROUND: Platelet‐poor plasma serotonin levels are associated with adverse cardiovascular outcomes. Although plasma serotonin levels increase in chronic kidney disease, the cardiovascular implications remain unknown. METHODS AND RESULTS: In 1114 participants from the prospective CRIC (Chronic Ren...
Autores principales: | Edmonston, Daniel, Isakova, Tamara, Wolf, Myles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547345/ https://www.ncbi.nlm.nih.gov/pubmed/37609990 http://dx.doi.org/10.1161/JAHA.123.029785 |
Ejemplares similares
-
Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
por: Edmonston, Daniel, et al.
Publicado: (2023) -
Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study
por: Hsu, Simon, et al.
Publicado: (2023) -
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis
por: Edmonston, Daniel L., et al.
Publicado: (2021) -
Echocardiography to Screen for Pulmonary Hypertension in CKD
por: Edmonston, Daniel L., et al.
Publicado: (2020) -
Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)